DABIGATRAN

Clinical Indication

Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation

Comments

Use in line with
DOAC Initiation Pack

Date of classification

June 2015

Review date

June 2015

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.